Stammdaten
Unternehmen
| Name | Maze Therapeutics, Inc. |
|---|---|
| Ticker | MAZE |
| CIK | 0001842295 |
Branche
| SIC-Code | 2836 |
|---|---|
| Beschreibung | Biological Products, (No Diagnostic Substances) |
Wertpapier
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Titel | Maze Therapeutics, Inc. |
Status
| Zuletzt geprüft | 2026-03-20 22:35:34.528415 |
|---|
Fondsaktivität (letzte 3 Quartale)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-20 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -5,044 | 50.02 | -252,293.82 | -69,8% | |
| 2026-03-20 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -3,795 | 49.32 | -187,168.64 | -51,8% | |
| 2026-03-20 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -6,161 | 48.20 | -296,976.83 | -82,2% | |
| 2026-03-20 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -5,044 | 50.02 | -252,293.82 | -69,8% | |
| 2026-03-20 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -3,795 | 49.32 | -187,168.64 | -51,8% | |
| 2026-03-20 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -6,161 | 48.20 | -296,976.83 | -82,2% | |
| 2026-03-10 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -348 | 51.02 | -17,753.22 | -4,9% | |
| 2026-03-10 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -29,652 | 50.45 | -1,495,807.00 | -413,8% | |
| 2026-03-02 | Bachrodt Amy | Officer, SVP, Finance | Open Market Sale | -3,700 | 45.47 | -168,236.78 | -46,5% | |
| 2026-03-02 | Bachrodt Amy | Officer, SVP, Finance | Open Market Sale | -1,300 | 44.44 | -57,773.82 | -16,0% | |
| 2026-02-27 | Dandekar Atul | Officer, CSBO | Open Market Sale | -3,739 | 45.13 | -168,756.03 | -46,7% | |
| 2026-02-27 | Dandekar Atul | Officer, CSBO | Open Market Sale | -3,761 | 45.72 | -171,967.21 | -47,6% | |
| 2026-02-02 | Bachrodt Amy | Officer, SVP, Finance | Open Market Sale | -736 | 46.63 | -34,321.37 | -9,5% | |
| 2026-02-02 | Bachrodt Amy | Officer, SVP, Finance | Open Market Sale | -200 | 44.15 | -8,830.00 | -2,4% | |
| 2026-02-02 | Bachrodt Amy | Officer, SVP, Finance | Open Market Sale | -4,064 | 46.03 | -187,067.95 | -51,8% | |
| 2026-02-02 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -600 | 44.21 | -26,523.00 | -7,3% | |
| 2026-02-02 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -8,364 | 45.89 | -383,816.43 | -106,2% | |
| 2026-02-02 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -5,936 | 46.37 | -275,271.32 | -76,2% | |
| 2026-02-02 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -100 | 47.23 | -4,723.00 | -1,3% | |
| 2026-02-02 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -600 | 44.21 | -26,523.00 | -7,3% | |
| 2026-02-02 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -8,364 | 45.89 | -383,816.43 | -106,2% | |
| 2026-02-02 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -5,936 | 46.37 | -275,271.32 | -76,2% | |
| 2026-02-02 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -100 | 47.23 | -4,723.00 | -1,3% | |
| 2026-01-29 | Dandekar Atul | Officer, CSBO | Open Market Sale | -2,800 | 45.01 | -126,022.40 | -34,9% | |
| 2026-01-29 | Dandekar Atul | Officer, CSBO | Open Market Sale | -3,500 | 44.04 | -154,146.65 | -42,6% | |
| 2026-01-29 | Dandekar Atul | Officer, CSBO | Open Market Sale | -1,200 | 43.18 | -51,821.28 | -14,3% | |
| 2026-01-22 | Bachrodt Amy | Officer, SVP, Finance | Open Market Sale | -5,000 | 45.52 | -227,612.00 | -63,0% | |
| 2026-01-07 | Sohn Catherine A. | Director | Open Market Sale | -26,920 | 39.11 | -1,052,784.67 | -291,3% | |
| 2026-01-07 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -25,156 | 40.20 | -1,011,298.87 | -279,8% | |
| 2026-01-07 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -25,156 | 40.20 | -1,011,298.87 | -279,8% | |
| 2026-01-06 | Sohn Catherine A. | Director | Open Market Sale | -2,493 | 38.62 | -96,269.69 | -26,6% | |
| 2026-01-05 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -412 | 40.00 | -16,480.00 | -4,6% | |
| 2026-01-05 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -412 | 40.00 | -16,480.00 | -4,6% | |
| 2026-01-02 | Bachrodt Amy | Officer, SVP, Finance | Open Market Sale | -2,405 | 38.70 | -93,072.30 | -25,8% | |
| 2026-01-02 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -4,432 | 40.43 | -179,187.53 | -49,6% | |
| 2026-01-02 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -4,432 | 40.43 | -179,187.53 | -49,6% | |
| 2026-01-02 | Bachrodt Amy | Officer, SVP, Finance | Open Market Sale | -2,595 | 39.57 | -102,681.30 | -28,4% | |
| 2025-12-30 | Bachrodt Amy | Officer, SVP, Finance | Open Market Sale | -5,000 | 40.08 | -200,407.00 | -55,4% | |
| 2025-12-30 | Dandekar Atul | Officer, CSBO | Open Market Sale | -100 | 40.36 | -4,036.00 | -1,1% | |
| 2025-12-29 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -17,200 | 40.93 | -703,930.64 | -194,8% | |
| 2025-12-29 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -17,200 | 40.93 | -703,930.64 | -194,8% | |
| 2025-12-29 | Bachrodt Amy | Officer, SVP, Finance | Open Market Sale | -600 | 41.16 | -24,694.98 | -6,8% | |
| 2025-12-29 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -27,800 | 40.34 | -1,121,424.20 | -310,3% | |
| 2025-12-29 | Bernstein Harold | Officer, President, R&D & CMO | Open Market Sale | -27,800 | 40.34 | -1,121,424.20 | -310,3% | |
| 2025-12-29 | Dandekar Atul | Officer, CSBO | Open Market Sale | -66,365 | 40.51 | -2,688,552.33 | -743,8% | |
| 2025-12-29 | Dandekar Atul | Officer, CSBO | Open Market Sale | -6,035 | 41.13 | -248,211.10 | -68,7% | |
| 2025-12-29 | Bachrodt Amy | Officer, SVP, Finance | Open Market Sale | -9,400 | 40.54 | -381,071.30 | -105,4% | |
| 2025-09-15 | SCHELLER RICHARD H | Director | Open Market Sale | -20,744 | 22.37 | -464,034.98 | -128,4% | |
| 2025-09-15 | SCHELLER RICHARD H | Director | Open Market Sale | -20,744 | 22.37 | -464,034.98 | -128,4% | |
| 2025-09-15 | SCHELLER RICHARD H | Director | Open Market Sale | -20,744 | 22.37 | -464,034.98 | -128,4% |
Top-Fondshalter (aktuelles Quartal)
Keine Fondsdaten für das aktuelle Quartal vorhanden.